Lamanan, Sheila Mae B.

HRN: 28-01-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2025
CEFTRIAXONE 1G (VIAL)
10/29/2025
11/04/2025
IV
1.3gm
OD
T/C CNSI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: